HCA Healthcare greenlights $10B buyback as outpatient services climb to 38.3%
THC•HCA Healthcare holds top-two inpatient share in 80% of its markets and plans to raise market share from 27% to 29% by 2030 as outpatient services now account for 38.3% of revenues. The company recorded 6.7% LTM revenue growth, trades at 12.3 PE multiple and approved a $10B buyback.
1. Market Position and Growth Strategy
HCA holds top-two inpatient share in about 80% of its service areas and is targeting a market share increase to 29% by 2030, driven by expansion of outpatient clinics and high-acuity service lines in fast-growing urban markets. Outpatient offerings now contribute over 38% of total patient revenues, reflecting a strategic pivot to higher-growth, lower-cost care settings.
2. Financial Fundamentals and Valuation
The company delivered 6.7% revenue growth in the last twelve months and a three-year average of 7.9%, while maintaining an LTM operating margin near 15.7%. Trading at a PE multiple of 12.3, HCA Healthcare remains valued below the S&P health care facilities median, suggesting potential upside if growth and margin trends persist.
3. $10 Billion Share Repurchase Program
Management authorized a $10 billion buyback, underscoring confidence in future free cash flow, which topped 10.4% of revenues last year. The program is expected to reduce outstanding shares, boost earnings per share and support the share price through ongoing capital return initiatives.
4. ACA Policy Headwinds and Investment Debate
A projected $600 million to $900 million EBITDA headwind from recent ACA reimbursement changes has sparked debate over the company’s resilience. While bullish investors point to HCA's operational efficiencies and scale, bearish views warn that payer mix deterioration could exceed guidance and pressure 2026 earnings.
